mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.062 |
0.1 |
mRNA |
ruxolitinib |
CTRPv2 |
pan-cancer |
AAC |
0.058 |
0.1 |
mRNA |
LY-2183240 |
CTRPv2 |
pan-cancer |
AAC |
0.053 |
0.1 |
mRNA |
CR-1-31B |
CTRPv2 |
pan-cancer |
AAC |
0.054 |
0.1 |
mRNA |
COL-3 |
CTRPv2 |
pan-cancer |
AAC |
0.06 |
0.1 |
mRNA |
nelarabine |
CTRPv2 |
pan-cancer |
AAC |
-0.063 |
0.1 |
mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.061 |
0.1 |
mRNA |
Methotrexate |
CTRPv2 |
pan-cancer |
AAC |
0.06 |
0.1 |
mRNA |
B02 |
CTRPv2 |
pan-cancer |
AAC |
-0.059 |
0.1 |
mRNA |
JQ-1:vorinostat (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.054 |
0.1 |